| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.03. | UPM-Kymmene Corporation: UPM Annual Report 2023, Corporate Governance Statement, Remuneration Report and Remuneration Policy published | 13 | GlobeNewswire (Europe) | UPM-Kymmene Corporation Annual Financial Report 1 March 2024 at 9:30 EET UPM Annual Report 2023, Corporate Governance Statement, Remuneration Report and Remuneration Policy published... ► Artikel lesen | |
| 01.03. | Acconeer AB: Bulletin from the Extraordinary General Meeting in Acconeer AB | 57 | GlobeNewswire (Europe) | Acconeer AB (the "Company") has today, 1 March 2024, held an Extraordinary General Meeting (the "EGM"). The EGM resolved approve the Board of Directors' proposal to amend the Articles of Association... ► Artikel lesen | |
| 01.03. | Canadian National Railway Company: CN Reaches New Tentative Collective Agreement with United Steelworkers | 253 | GlobeNewswire (Europe) | MONTREAL, March 01, 2024 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) announced today that a new tentative three-year collective agreement has been reached with the United Steelworkers (USW) Local... ► Artikel lesen | |
| 01.03. | Taysha Gene Therapies, Inc.: Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 273 | GlobeNewswire (Europe) | DALLAS, March 01, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for... ► Artikel lesen | |
| 01.03. | Kura Oncology, Inc.: Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 240 | GlobeNewswire (Europe) | SAN DIEGO, March 01, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the "Company") (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines... ► Artikel lesen | |
| 01.03. | ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 144 | GlobeNewswire (Europe) | SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 01, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address... ► Artikel lesen | |
| 01.03. | Mega Matrix Corp: Mega Matrix Announces Inspiring Operating Metrics for the First Two Months of 2024 | 203 | GlobeNewswire (Europe) | PALO ALTO, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- Mega Matrix Corp. (NYSE American: MPU) (the "Company" or "MPU") today announced FlexTV's operating metrics for the first two months of 2024. Following... ► Artikel lesen | |
| 01.03. | G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 254 | GlobeNewswire (Europe) | RESEARCH TRIANGLE PARK, N.C., March 01, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the grant of inducement stock options exercisable... ► Artikel lesen | |
| 01.03. | Power Solutions International, Inc.: Power Solutions International Appoints Randall Lehner as General Counsel | 323 | GlobeNewswire (Europe) | WOOD DALE, Ill., March 01, 2024 (GLOBE NEWSWIRE) -- Power Solutions International, Inc. (the "Company") today announced that on February 7, 2024, the Board of Directors of the Company appointed Randall... ► Artikel lesen | |
| 01.03. | Molecular Partners Announces Dismissal of Class Action Lawsuit | 255 | GlobeNewswire (Europe) | ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 01, 2024 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built... ► Artikel lesen | |
| 01.03. | Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 304 | GlobeNewswire (Europe) | REDWOOD CITY, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA) ("Biomea" or the "Company"), a clinical stage biopharmaceutical company focused on the discovery and development... ► Artikel lesen | |
| 01.03. | Magic Empire Global Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency | 346 | GlobeNewswire (Europe) | Hong Kong, March 01, 2024 (GLOBE NEWSWIRE) -- Magic Empire Global Limited (NASDAQ: MEGL) ("MEGL", or the "Company") announced that, on February 28, 2024, the Company received a letter from the Listing... ► Artikel lesen | |
| 01.03. | Trio Petroleum Corp.: Trio Petroleum Announces Notice of Noncompliance with NYSE American Listing Standards | 230 | GlobeNewswire (Europe) | Bakersfield, CA, March 01, 2024 (GLOBE NEWSWIRE) -- Trio Petroleum Corp (NYSE American: TPET) ("TPET", "Trio" or the "Company"), a California-based oil and gas company, today announced that on February... ► Artikel lesen | |
| 01.03. | Cipher Mining Inc.: Cipher Mining Announces February 2024 Operational Update | 180 | GlobeNewswire (Europe) | NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- Cipher Mining Inc. (NASDAQ:CIFR) ("Cipher" or the "Company") today released its unaudited production and operations update for February 2024. Key Highlights... ► Artikel lesen | |
| 01.03. | X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 277 | GlobeNewswire (Europe) | BOSTON, March 01, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective... ► Artikel lesen | |
| 01.03. | NurExone Biologic Inc: NurExone Presenting Novel Regulatory Pathways for Exosomes Therapies at Global Summit | 316 | GlobeNewswire (Europe) | TORONTO and HAIFA, Israel, March 01, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the "Company" or "NurExone"), a pioneering biopharmaceutical company, is pleased to... ► Artikel lesen | |
| 01.03. | Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 195 | GlobeNewswire (Europe) | WATERTOWN, Mass., March 01, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) ("Lyra" or the "Company"), a clinical-stage biotechnology company developing long-acting, anti-inflammatory... ► Artikel lesen | |
| 01.03. | Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 278 | GlobeNewswire (Europe) | BOSTON, March 01, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing... ► Artikel lesen | |
| 01.03. | Cytokinetics, Incorporated: Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 235 | GlobeNewswire (Europe) | SOUTH SAN FRANCISCO, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on February 29, 2024 it granted stock options to purchase an aggregate... ► Artikel lesen | |
| 01.03. | Stellantis N.V.: Weekly Report (February 28-29, 2024) on the First Tranche of Stellantis 2024 Share Buyback Program | 435 | GlobeNewswire (Europe) | Weekly Report (February 28-29, 2024) on the First Tranche of Stellantis 2024 Share Buyback Program AMSTERDAM, March 1, 2024 - Stellantis N.V. ("Stellantis" or the "Company") announced today that pursuant... ► Artikel lesen |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| PALANTIR TECHNOLOGIES | 2.477 |
| EVOTEC | 2.296 |
| NEL | 2.223 |
| INFINEON | 1.687 |
| TUI | 1.553 |
| BAYER | 1.350 |
| DEUTSCHE BANK | 1.234 |
| NVIDIA | 1.185 |
| DEUTSCHE LUFTHANSA | 1.123 |
| BYD | 1.033 |
| VARTA | 996 |
| RHEINMETALL | 934 |
| MERCEDES-BENZ | 887 |
| AIXTRON SE | 828 |
| SUPER MICRO COMPUTER | 827 |
| TESLA | 824 |
| RENK GROUP | 823 |
| PLUG POWER | 813 |
| TEAMVIEWER | 812 |
| COMMERZBANK | 768 |
| RWE | 766 |
| ALLIANZ | 742 |
| SIEMENS ENERGY | 731 |
| VOLKSWAGEN | 711 |
| WALT DISNEY | 695 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
